Retatrutide

20 MG / VIAL>99% HPLCPGX-RTT-20

PURITY

>99%

FORMAT

Lyophilized

DOSE

20 mg / vial

STORAGE

2–8°C

INCLUDED WITH VIAL

Each vial ships with its respective reconstitution water.

VIEW RECONSTITUTION WATER

Overview

Retatrutide is a research compound classified as a triple agonist that acts on the GLP-1, GIP, and glucagon receptors. Its pharmacological profile makes it an advanced model for studying energy-metabolism regulation and endocrine signaling. Across preclinical work it is frequently used to investigate how converging incretin and glucagon pathways shape whole-body energy balance.

Research areas

01
Regulation of complex metabolic pathways
02
Hormonal signaling (GLP-1 / GIP / glucagon)
03
Cellular energy-balance control
04
Glucose homeostasis in preclinical models
05
Systemic metabolism studies

Specifications

PURITY: >99% (HPLC verified)
FORMAT: Lyophilized powder
QUANTITY: 20 mg per vial
STORAGE: 2–8°C
HANDLING: Laboratory research use only

Handling protocol

COLD CHAIN

2–8°C

PROTECTION

Light-shielded

USE

Research only

Scientific notes

Its triple mechanism of action makes Retatrutide a compound of high interest for advanced metabolic models, particularly in studies that explore the convergence of incretin and glucagon-related signaling on whole-body energy regulation. The compound is used as a reference in research comparing single-, dual-, and multi-receptor agonism.

RESEARCH USE ONLY · NOT FOR HUMAN CONSUMPTION

Get it now Contact

Other compounds in the catalog

CJC-1295 + Ipamorelin